Janney Montgomery Scott LLC trimmed its position in Abrdn Healthcare Investors (NYSE:HQH – Free Report) by 1.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 155,632 shares of the financial services provider’s stock after selling 2,018 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Abrdn Healthcare Investors were worth $2,898,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. MONECO Advisors LLC acquired a new stake in shares of Abrdn Healthcare Investors during the third quarter worth approximately $361,000. International Assets Investment Management LLC acquired a new stake in Abrdn Healthcare Investors in the third quarter valued at approximately $682,000. Private Advisor Group LLC lifted its stake in Abrdn Healthcare Investors by 3.6% in the third quarter. Private Advisor Group LLC now owns 38,804 shares of the financial services provider’s stock valued at $723,000 after acquiring an additional 1,356 shares during the last quarter. Northwest Investment Counselors LLC acquired a new stake in Abrdn Healthcare Investors in the third quarter valued at approximately $57,000. Finally, Raymond James & Associates lifted its stake in Abrdn Healthcare Investors by 79.8% in the third quarter. Raymond James & Associates now owns 355,205 shares of the financial services provider’s stock valued at $6,614,000 after acquiring an additional 157,618 shares during the last quarter. 32.60% of the stock is currently owned by institutional investors and hedge funds.
Abrdn Healthcare Investors Trading Up 0.3 %
NYSE HQH opened at $18.73 on Tuesday. The company has a 50 day moving average price of $18.54 and a two-hundred day moving average price of $18.01. Abrdn Healthcare Investors has a 12-month low of $14.58 and a 12-month high of $19.79.
Abrdn Healthcare Investors Company Profile
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Further Reading
- Five stocks we like better than Abrdn Healthcare Investors
- Roth IRA Calculator: Calculate Your Potential Returns
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What is Put Option Volume?
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- What Does Downgrade Mean in Investing?
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abrdn Healthcare Investors (NYSE:HQH – Free Report).
Receive News & Ratings for Abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.